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2Abstract
Background: Studies suggest that women may be at greater risk for developing chronic pain 
and pain-related disability. Methods: Because musculoskeletal disorders (MSD) are the most 
frequently endorsed painful conditions among veterans, we sought to characterize gender differences 
in sociodemographic and clinical correlates among veterans upon entry into VHA’s Musculoskeletal 
Disorders Cohort (N=4,128,008). Results: Women were more likely to be younger, Black, unmarried, 
and veterans of recent conflicts. In analyses adjusted for gender differences in sociodemographics, 
women were more likely to have diagnoses of fibromyalgia, temporomandibular disorders, and neck 
pain. Almost one in five women (19.4%) had more than one MSD diagnosis, compared to 15.7% of 
men; this higher risk of MSD multimorbidity remained in adjusted analyses.  Adjusting for 
sociodemographics, women with MSD were more likely to have migraine headache and depressive, 
anxiety, and bipolar disorders. Women had lower odds of cardiovascular diseases, substance use 
disorders, and several MSDs, including back pain conditions. Men were more likely to report “no pain” 
on the pain intensity numeric rating scale (NRS), whereas more women (41%) than men (34%) 
reported moderate to severe pain (NRS 4+). Conclusion: Because women veterans are more likely 
to have conditions such as fibromyalgia and mental health conditions, along with greater pain 
intensity in the setting of MSD, women-specific pain services may be needed.
3Introduction
The number of Veterans accessing Veterans Health Administration (VHA) care increased from 
6.8 million in 2002 to 8.9 million in 2013 (U.S. Department of Veterans Affairs, 2016). While the 
veteran population is projected to decrease substantially by 2043, the proportion of women veterans 
is projected to increase (National Center for Veterans Analysis and Statistics, 2014).  Understanding 
the unique healthcare needs of women veterans is a priority for VHA. 
A recent report on pain and pain management from the Institute of Medicine (IOM) identified 
both women and veterans as vulnerable groups (Institute of Medicine of the National Academies, 
2011).  A review of non-veteran samples suggests that women have a higher prevalence of 
musculoskeletal pain, neuropathic pain, and fibromyalgia than men (Fillingim, King, Ribeiro-Dasila, 
Rahim-Williams, & Riley, 2009). Similarly, rates of chronic pain are higher among women veterans 
relative to men (Haskell et al., 2012; Higgins et al., 2014), with prevalence rates as high as 78% 
(Haskell, Heapy, Reid, Papas, & Kerns, 2006). Among veterans reporting pain, women were more 
likely than men to have moderate/severe pain (Haskell et al., 2009). Among returning Operations 
Enduring Freedom/Iraqi Freedom/New Dawn (OEF/OIF/OND) veterans, musculoskeletal disorders 
(MSD), often associated with pain, are among the most frequently reported conditions, with 
prevalence especially high among women (Haskell et al., 2011).  An examination of veterans with 
moderate or severe chronic pain receiving VHA care in the Pacific Northwest revealed several gender 
differences (Weimer et al., 2013). Specifically, women were more likely to have painful conditions 
including fibromyalgia, low back pain, migraine headache, neck or joint problems, and 
rheumatism/arthritis. Women veterans with chronic pain also had higher body mass index and more 
mental health diagnoses, but fewer substance use disorders, than men (Weimer et al., 2013). 
There are several gaps in the literature characterizing gender differences in pain-relevant 
disorders. Only two previous studies have specifically examined gender differences in the prevalence 
of painful disorders (Weimer et al., 2013; Haskell, et al, 2012); the first included regional, not national 
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the larger veteran population. Additionally, little is known about presence of pain at MSD diagnosis 
and comorbidities of these conditions among veterans. Most studies focus on pain severity, not MSD, 
and have been limited to samples of OEF/OIF/OND veterans (Haskell et al., 2009; 2012). This 
limitation is particularly significant because these veterans are, on average, younger and more 
racially and ethnically diverse than previous veteran cohorts.  It is important to examine gender 
differences in pain intensity, MSD and comorbidities, given the high volume of veterans seeking 
health care each year for MSD and pain, and the increasing number of women seeking VHA care 
(Goulet et al., 2016).
The purpose of the current investigation is to characterize gender differences in relative 
proportion of specific pain-relevant diagnoses and sociodemographic characteristics, along with 
medical and mental health comorbidities at MSD diagnosis among veterans receiving VHA care. 
Methods
Study population
Electronic searches for International Classification of Diseases, 9th Revision, Clinical 
Modification (ICD-9CM) codes consistent with musculoskeletal disorders (MSD) were conducted to 
define the cohort (Goulet et al., 2016).). 
Defining MSD: A total of 1,685 distinct ICD-9CM codes were identified and consolidated into 14 MSD 
groupings encompassing conditions of the back and neck, osteoarthritis, fractures, and inflammatory 
and degenerative disorders (Goulet et al., 2016). We searched VHA electronic clinical and 
administrative data for all outpatient and inpatient records with an MSD diagnosis noted between 
January 1, 2000 and December 31, 2013. For cohort inclusion, a veteran had to have two or more 
outpatient visits with an MSD diagnosis occurring within 18 months of one another, or one or more 
inpatient admissions with an MSD diagnosis (Justice et al., 2006). There were no other inclusion or 
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observed outpatient clinic visit or inpatient admission with an MSD diagnosis. The second ICD-9CM 
code served to validate the first MSD diagnosis. It was possible for a veteran to meet criteria for more 
than one MSD diagnosis on the index date. Because a confirmatory outpatient visit within 18 months 
of the MSD index date was required, data included only those veterans identified with an MSD 
between 2000 and 2011. See Goulet and colleagues (2016) for a detailed description of the MSD 
Cohort. The cohort was designed to be inclusive, therefore, we did not exempt patients whose MSD 
diagnoses changed between entry into the cohort and follow-up, as we have found that it generally 
does not change. For example, the diagnosis at time one was the same at time two in 95% of 
“osteoarthritis” diagnoses.
Variables
Sociodemographics: Sociodemographic characteristics of MSD Cohort members at the index date 
including age, gender, race/ethnicity, marital status, and OEF/OIF/OND status were examined.
Painful Conditions (MSD): We examined the most common diagnostic groups of MSD, including 
osteoarthritis, non-traumatic joint disorders (e.g., arthropathies, ankylosis), back pain, neck pain, 
osteoporosis, sprain and strain, fibromyalgia, fracture, traumatic joint disorder, rheumatoid arthritis, 
temporomandibular disorders (TMD), lupus, gout, spinal cord injury, “other” (all MSD which did not fit 
into the 14 specific diagnostic groupings), and MSD multimorbidity (more than one MSD diagnosed at 
cohort entry). 
Medical and Mental Health Characteristics: High-prevalence, high-impact (Kazis et al., 1998; Yu et 
al., 2003) medical and mental health comorbid diagnoses were identified using the same criteria as 
MSD diagnoses (i.e., two or more outpatient codes within 18 months, or one or more inpatient code). 
However, only comorbid conditions noted in the year prior to and up to six months after the MSD 
6index date were retained for the analysis, as they were likely to be active at MSD diagnosis 
(concurrent comorbidity). 
Cardiovascular comorbidities and cardiac risk factors (i.e., congestive heart failure, coronary 
artery disease [CAD], hypertension [HTN], hemorrhagic stroke, ischemic stroke, peripheral vascular 
disease), smoking status (i.e., categorized as never, past, current) and overweight/obesity as 
determined by body mass index (BMI), were examined as medical comorbidities because of their high 
prevalence among veterans (Kazis et al., 1998; Yu et al., 2003). BMI was calculated from the height 
and weight data on or closest to the MSD index date within the year prior to or up to six months after. 
BMI classifications (kg/m2) used for analyses in this study were based on standard cutoffs as follows: 
underweight (BMI less than 18.5), normal weight (BMI 18.5-24.9), overweight (BMI 25 to 29.9), 
obesity (BMI 30+) (National Heart, Lung, and Blood Institute, 1998). Migraine was also included 
because prior studies have identified gender differences in this disorder (Fillingim et al., 2009; 
Weimer et al., 2013).  Literature examining gender differences in medical comorbidities associated 
with painful conditions is limited but lends support for the comorbidities included in the current study. 
For example, Weimer and colleagues (Weimer et al., 2013) adjusted for Charlson comorbidity score, 
but did not specify medical conditions that were more prevalent among women veterans with painful 
conditions.  Mental health conditions examined included depressive disorders (i.e., major depressive 
disorder, dysthymia, depression due to other causes or not otherwise specified), bipolar disorder, 
anxiety disorders (i.e., anxiety state not otherwise specified [NOS]/not elsewhere classified [NEC], 
panic disorder, generalized anxiety disorder, nervousness), PTSD, alcohol use disorders, and drug 
use disorders. 
Pain Intensity Ratings: The Numeric Rating Scale (NRS) is used in routine clinical care to screen for 
the presence and intensity of pain at most clinical encounters when other vital signs are obtained 
(Veterans Health Administration, 2000). Patients are asked, “On a scale of 0 to 10, where 0 means no 
7pain and 10 means the worst possible pain, what is your current pain level?” NRS pain scores were 
identified on the MSD index day. When multiple NRS were recorded on the index date, we retained 
only the highest. An invalid NRS (i.e., a score that was not an integer value 0-10) was considered 
missing. NRS was invalid or missing in 19.7% of cases for women and 19.4% of cases for men. The 
NRS was categorized using standard cutoffs: 0=no pain, 1 to 3=mild pain, 4 to 6=moderate pain, and 
7 or greater=severe pain (Tan, Jensen, Thornby, Rintala, & Anderson, 2008).
The study was approved by the Institutional Review Board at VA Connecticut Healthcare System--
West Haven, CT.
Statistical analysis
Chi-square tests were used to examine unadjusted relationships between categorical covariates and 
gender and odds ratios presented. To adjust for confounding due to sociodemographic differences 
between women and men, we used logistic regression to calculate adjusted odds ratios (AOR) and 
95% confidence intervals (CI) to assess the association of gender with MSD group as well as 
comorbidities among veterans with MSD. SAS (SAS 9.4, Cary, NC) was used for all analyses. In 
Tables 2-4, the variables controlled in the adjusted analyses were age, race/ethnicity, marital status, 
and OEF/OIF/OND status. Given the large sample, meaningful differences, consistent with criteria 
used by Goulet et al. (2016), required a 2% absolute difference or 2-fold difference in odds ratios.
Another factor considered in the present study is the relative impacts of unadjusted compared 
with adjusted analyses results. Unadjusted analyses describe the particular VHA population (i.e., all 
veterans in VHA care with MSD), such that observed differences may reflect gender differences in 
sociodemographics and comorbidities. The presentation of unadjusted results is important from a 
VHA policy and planning perspective. The adjusted analyses results are more generalizable with 
respect to understanding gender differences in MSDs among patients receiving care outside of the 
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variables that might obscure or distort the relationship between gender and disease prevalence.  
Because women veterans are more likely to be non-white and younger than men, with unadjusted 
analyses, we might risk attributing findings to gender when the results might instead be a function of 
younger age and non-white race.
Results
Sociodemographic characteristics: The sample consisted of 253,383 women (6.1%) and 3,874,625 
men veterans (N=4,128,008). Women were younger, and more likely unmarried, Black, and an 
OEF/OIF/OND era veteran (Table 1; all significant at p<.0001).
******Insert Table 1 about here*******
Gender-differences in specific MSDs: Specific MSDs in women and men were examined at cohort 
entry. These disorder categories are not mutually exclusive.  All differences in Table 2 reached 
significance at p<.0001, except rheumatoid arthritis (p=.056). Gender differences in 9 of 16 (56%) 
diagnostic groupings reached the threshold of a 2% absolute difference between women and men. 
Differences in non-traumatic joint disorders (women>men), back pain (women>men), and 
osteoarthritis (men>women), among others, were found to be clinically important. Almost one in five 
women (19.4%) had >1 MSD diagnosis upon cohort entry, while 15.7% of men did. 
When age, race/ethnicity, marital status, and OEF/OIF/OND status were controlled for in 
adjusted analyses, all differences between women and men were significant except non-traumatic 
joint disorder.  However, the direction of some associations changed. Specifically, women had 
significantly lower rates of osteoarthritis, back pain, sprain/strain, traumatic joint disorder, and gout 
than men.  
9******Insert Table 2 about here*******
Medical and mental health comorbidities among veterans with MSD: Results of unadjusted analyses 
are presented in Table 3. Women were less likely to have vascular disorders, overweight/obesity, and 
smoking, but more likely to have a migraine diagnosis. These associations remained unchanged in 
adjusted models. All associations were significant at p < .0001. 
******Insert Table 3 about here*******
Results of unadjusted and adjusted analyses of gender differences in the prevalence of mental 
health comorbidities are presented in Table 4.  All unadjusted and adjusted odds ratios were 
significant at p<.0001. Unadjusted ORs show women were significantly more likely to have bipolar 
disorder, depressive disorder, anxiety disorder, and PTSD. Men were more likely to have alcohol use 
and drug use disorders. Patterns remained after adjustment for sociodemographic variables, except 
PTSD.  After adjustment, men were more likely to have PTSD concurrent with their MSD diagnosis. 
Clinically-meaningful gender differences (i.e., an absolute difference across genders of 2%) were 
observed in alcohol use disorder, bipolar disorder, and depressive and anxiety disorders. 
******Insert Table 4 about here*******
Pain intensity: On MSD cohort entry, both men and women had a wide range of pain intensity ratings, 
with more men reporting no pain (34% for men vs. 28% for women). More women (41%) than men 
(34%) reported moderate or severe pain (pain intensity NRS 4+), often suggested as a clinically-
actionable rating. Figure 1 demonstrates the frequencies of women and men reporting no pain, mild, 
moderate, and severe pain (p<.0001). 
******Insert Figure 1 about here*******
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Discussion
Our study highlights gender differences in veterans with MSD. Notably, women veterans with 
MSD are younger, more likely to be black, unmarried, and OEF/OIF/OND-era veterans. Consistent 
with prior research, women veterans with MSD were more likely than men to report moderate and 
severe pain, while men were more likely to report no pain (e.g., Haskell et al., 2009; 2012; Higgins et 
al., 2014). Adjusted analyses, discussed below, describe gender differences in MSD and its 
correlates among veterans in VHA care that are likely to be generalizable beyond those veterans 
receiving VHA care.  
One study of the prevalence of MSD among post-deployment OEF/OIF/OND veterans (Haskell 
et al., 2012) demonstrated that, after controlling for sociodemographic characteristics, women were 
more likely to have back conditions and joint disorders than men. In contrast, adjusted analyses in the 
current study show that women veterans were less likely to have diagnoses of back conditions, 
sprain/strain, and traumatic joint disorder and there was no significant gender difference in non-
traumatic joint disorder. This is potentially explained by the fact that women in this sample were 
younger and these diagnoses are often associated with older age. This discrepancy may also reflect 
the difference in study design, variation in time since last deployment, as well as MSD case 
definitions. Specifically, Haskell et al (2012) focused solely on veterans of the OEF/OIF/OND era in 
VHA care, regardless of presence of MSD. The current study contains a sample of all veterans 
receiving VHA care with one or more MSD. Veterans of different eras are likely to have encountered 
unique physical challenges, including different occupational roles for women in recent eras,  and 
those of earlier conflicts (e.g., Vietnam) may be more likely to experience painful conditions affected 
by aging (e.g., osteoarthritis of lumbar spine). Compared with men, women with MSD in the current 
study were significantly more likely to have neck pain, fibromyalgia, and TMD diagnoses, consistent 
with prevalence rates of these conditions in both veteran (Weimer et al., 2013) and non-veteran 
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samples (Fillingim et al., 2009). Taken together, results of the current study reflect that women 
veterans with MSD appear similar in MSD prevalence of certain conditions (e.g., TMD, fibromyalgia) 
and pain intensity to their non-veteran counterparts. However, the finding that women veterans with 
MSD are less likely to have back pain conditions after controlling for sociodemographics is intriguing 
because it is inconsistent with a large literature. Also of note, women veterans were more likely to 
have MSD multimorbidity than men, suggesting women may have a higher burden of illness.
Consistent with previous studies, women with MSD were at lower risk of cardiovascular 
comorbidities and cardiac risk factors, including overweight/obesity and smoking, but were more likely 
to have depressive disorders, anxiety disorders, and bipolar disorder, even after adjusting for 
important sociodemographic factors. Women veterans were at significantly higher risk of migraine 
headaches compared to men. The PTSD finding in the unadjusted analyses was somewhat 
surprising, as other data suggest that men are more likely to report PTSD than women veterans 
(Freedy et al., 2010); however, this finding in the current study can be accounted for by 
sociodemographic differences (e.g., age, race/ethnicity) between men and women in the MSD 
Cohort.
These results suggest that women veterans with MSD are an important and unique and 
growing subgroup of veterans, whose particular needs should be considered with respect to clinical 
and policy implications. Women are more likely to be racial/ethnic minorities and may have different 
healthcare (U.S. Department of Veterans Affairs, 2016) and psychosocial experiences as a result. 
They are also younger and have fewer cardiovascular and cardiac risk factors but, in the current 
study, women were more likely to report moderate and severe pain. This level of pain intensity may 
have a larger impact on their physical, social, and emotional functioning. Improved access to 
interventions that foster adaptive pain self-management (as suggested by the IOM; Institute of 
Medicine of the National Academies, 2011) such as cognitive behavioral therapy for chronic pain, 
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seems intuitive for addressing these problems in women veterans. In addition, women veterans may 
have other, differential healthcare needs. For example, the rates of mental health conditions are high 
for both men and women in the current study, but are even higher among women. A recent study 
examining provision of women-specific programs for substance use disorders reported that VHA had 
fewer of these programs than other federal, state, local, tribal, and private healthcare facilities (Heslin, 
Gable, & Dobalian, 2015). Greater attention to comorbid depressive and substance use disorders 
may be indicated for all veterans with MSD, particularly women. Sensitivity to sexual orientation 
should also be considered within this context. Data suggest that the subpopulation of lesbian and 
bisexual women veterans is more likely to have experienced military and childhood sexual trauma 
and are more likely to engage in unsafe alcohol consumption, and to rate their mental health as 
worse than prior to deployment than their heterosexual counterparts (Mattocks, et al, 2013).
This is one of the few studies that examined gender differences in pain intensity at the time of 
MSD diagnosis. In contrast to much of the existing literature which examines pain intensity in samples 
of patients with existing chronic pain (Haskell et al., 2009; Weimer et al., 2013), the current study 
examined pain intensity on the day of MSD diagnosis (i.e., diagnosis occurring in the context of VHA 
care, specifically). For example, other studies (Haskell et al., 2009) focused on pain intensity at the 
initial pain screening, for any condition, in the first year of VHA treatment. Because the screening did 
not have to be associated with a pain diagnosis, it is unclear what prompted the patients’ pain reports. 
One additional strength of the current study is that the pain intensity NRS is assessed at the time the 
MSD is diagnosed, allowing an inference to be made that the pain report is directly related to the 
MSD(s).  
One limitation of this cohort is its sole reliance on existing electronic medical record (EMR) 
data for defining chronic pain conditions (MSD). It is possible that veterans in VHA care have MSDs 
but do not have diagnoses in the EMR and were not captured in the sample. In addition, a fairly large 
proportion of the sample had missing pain NRS values. This may reflect that these data were entered 
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incorrectly into the vital signs section of the EMR, or that patients were not asked about pain intensity 
during their clinical visit.  Our reliance on pain intensity NRS at one time point (i.e., cohort entry) limits 
our ability to describe the intensity of a given patient’s chronic pain longitudinally. Finally, the fact that 
there were so many pain intensity NRS scores of 0 may reflect the intermittent nature of pain among 
veterans with MSD.
Implications for Practice and Policy
The current study suggests that there is evidence of gender difference in some MSDs. The 
gender differences in mental health comorbidity among veterans with MSD suggest that veterans, 
particularly women, with chronic pain may benefit from multidisciplinary treatment models such as 
combined treatment for pain and depression (Kroenke et al., 2009; Stubbs et al., 2010). Women 
veterans may also benefit from non-pharmacologic and complementary and integrated health (CIH) 
approaches to manage MSD and comorbid conditions. For example, one study has found that women 
veterans receive more benefit (e.g., decrease in average pain and depression) from yoga for low 
back pain than men (Groessl, Weingardt, Johnson, Baxi, 2012). VHA and other organizations have 
made recent strides in recommending and expanding non-pharmacologic pain management options 
through their policy and practice efforts, including a recent State Of The Art Conference on Non-
pharmacological Approaches to Management of Chronic Musculoskeletal Pain (VHA Office of 
Research and Development Health Services Research & Development SOTA, November 2016) that 
will provide some practice policy and research recommendations, including a focus on CIH delivery. 
The Comprehensive Addiction Recovery Act (CARA; United States 114th Congress, 2015-2016) 
highlights provisions for building capacity for CIH and integrated pain teams. Finally, the VHA’s Office 
of Patient Centered Care and Cultural Transformation is undertaking a major “Whole Health” patient-
centered initiative focused on CIH.  
Treatment delivery modes may also have to account for barriers in access to care (e.g., 
childcare responsibilities, work schedules) for women veterans with MSD who are younger. 
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Telehealth approaches, such as interactive voice response (Heapy et al., 2016) and others (e.g., 
internet, telephone) have been shown to be effective for delivering behavioral pain self-management 
(Heapy, Higgins, Wandner, Cervone, & Kerns, 2015). Video-teleconferencing equipment has been 
successfully used to deliver treatment for pain and depression associated with trauma in women 
veterans (Tan et al., 2013). These delivery modalities may address barriers to pain care among 
women veterans.
Pain intensity, which was higher in women with MSD in the current study, is likely to present as 
an additional barrier to other previously mentioned challenges – both complicating the management 
of those comorbidities and making it more difficult to manage patients’ pain in the context of those 
competing priorities (Butchart, Kerr, Heisler, Piette, & Krein, 2009). Indeed, women veterans have a 
harder time sustaining improvements in pain intensity following engagement in an intensive inpatient 
pain rehabilitation program relative to men (Murphy, Phillips, & Rafie, 2016). These challenges point 
to the importance of comprehensive pain assessment using a biopsychosocial framework, as 
suggested by the IOM (Institute of Medicine of the National Academies, 2011) and VHA pain 
management guidelines. Further, it will be important for VHA to develop a women’s healthcare 
workforce that is specifically trained to conduct comprehensive pain assessment and treatment that 
addresses the needs of women veterans with chronic pain.
Research efforts to address the pain care needs of veterans, including women, have been 
expanded as well. A recent publication of partnered funding opportunities between VHA, the 
Department of Defense, and the National Institutes of Health (NIH), including the NIH Office of 
Women’s Health Research, focused on non-pharmacological approaches to pain 
management. Further, the Department of Health and Human Service’s National Pain Strategy 
(DHHS, 2016) highlights the need to address disparities in pain care so that disparities can be 
identified and characterized, allowing for examination of their root cause(s) and whether or not the 
root cause(s) are modifiable. Intervention mapping or targeting can be used to modify (tailor) and 
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improve services for women Veterans with MSD. For example, a collaborative care or peer-led 
intervention that assesses the unique needs and treatment preferences of women veterans and 
tailors intervention content and delivery to reduce identified disparities may lead to improved 
outcomes. Such research has broad-reaching practice and policy implications. 
Conclusions
The proportion of women in the military, their roles, demographics, and exposure to combat 
have changed dramatically during OEF/OIF/OND. VHA must anticipate and prepare not only for 
increasing numbers of women Veterans enrolling in care, but also for the accompanying complexity 
and longevity of associated treatment needs. To begin the task of developing women veteran-specific 
pain treatment programs, it is vital to understand the patient-level characteristics among veterans with 
MSD, as well as to understand pain chronicity after MSD diagnosis. These analyses suggest that 
services targeting women veterans with MSD may be needed, particularly those tailored to the needs 
of women who are younger, black, and/or have limited spousal supports or mental health 
comorbidities. A focus on addressing specific painful conditions most commonly reported by women 
veterans with MSD such as fibromyalgia, TMD, and neck pain is also warranted.
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Table 1: Sociodemographics of women and men who entered into the MSD Cohort 2001-2011
Women
(N=253,383)
Percent 
Men
(N=3,874,625)
Percent
Age
<40 38.8 12.1
40-49 26.9 12.4
50-64 22.6 38.3
65+ 11.7 37.2
Race/ethnicity
Black 25.5 14.4
Hispanic 5.4 4.8
White 59.4 74.2
Other 2.9 2.4
Unknown 6.8 4.1
Marital status
Married 33.9 56.5
Not Married 22.1 10.6
Sep/Divorced 35.7 24.5
Widowed 7.7 8.1
Unknown 0.6 0.3
Positive OEF/OIF/OND* 14.0 7.0
* Veterans of the Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn conflicts 
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Figure 1. Pain intensity at entry into the cohort—Women compared to Men
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Table 2: Specific MSDs in women and men (unadjusted & adjusted ORs, women compared to 
men)*
Unadjusted analyses Adjusted analyses
 
Women
N=253,363
Percent
Men
N=3,874,625
Percent
Unadjusted OR 
(95% CI)
Adjusted OR
(95% CI)
Non-traumatic joint 
disorder§ 32.5 27.9
1.24 (1.23, 1.25) 1.00 (0.99, 1.01) 
Back pain § 28.3 25.8 1.14 (1.13,1.15) 0.87 (0.86, 0.88)
Osteoarthritis § 11.6 19.9 0.53 (0.52,0.53) 0.90 (0.89, 0.91) 
Neck pain 7.0 5.2 1.39 (1.36, 1.41) 1.20 (1.18, 1.22)
Osteoporosis § 4.7 1.3 3.66 (3.59, 3.74) 11.02 (10.77, 11.28) 
Sprain and strain 4.4 3.0 1.51 (1.48, 1.54) 0.93 (0.91, 0.95) 
Fibromyalgia § 3.0 1.0 3.04 (2.96, 3.11) 2.81 (2.74, 2.89) 
Fracture 2.7 3.2 0.84 (0.82, 0.86) 0.62 (0.61, 0.64)
Traumatic joint 
disorder 1.9 1.5
1.29 (1.26, 1.33) 0.77 (0.75, 0.79)
Rheumatoid arthritis 1.1 1.0 1.04 (1.00,1.08) 1.81 (1.74, 1.88)
Temporomandibular 
disorders § 
1.1 0.3 4.48 (4.30, 4.68) 2.96 (2.83, 3.10) 
Lupus § 0.7 0.2 4.77 (4.53, 5.02) 5.46 (5.16, 5.79) 
Gout § 0.4 5.4 0.07 (0.07, 0.08) 0.13 ( 0.12, 0.14)
Spinal Cord injury 0.1 0.2 0.34 (0.29, 0.40) 0.26 (0.22, 0.31)
Other 23.4 22.1 1.08 (1.07,1.09) 1.18 (1.17, 1.20)
MSD multimorbidity § 19.4 15.7 1.29 (1.28, 1.31) 1.14 (1.13, 1.15) 
*p<0.001
**P<0.056
§ indicates a clinically meaningful difference (i.e., absolute difference of 2%)
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Table 3: Comorbid cardiovascular & other conditions (unadjusted & adjusted ORs, women 
compared to men)*
Unadjusted analyses Adjusted analyses 
Women Men Unadjusted OR 
(95% CI)
Adjusted OR (95% CI)
Congestive heart failure § 1.0 3.7 0.25 (0.24, 0.26) 0.51 (0.49, 0.53) 
Coronary artery disease § 2.9 16.7 0.15 (0.15, 0.15) 0.34 (0.33, 0.35) 
Hypertension§ 25.3 50.3 0.33 (0.33, 0.33) 0.65 (0.64, 0.66) 
Hemorrhagic stroke 0.1 0.2 0.55 (0.49, 0.61) 0.71 (0.63, 0.80)
Ischemic stroke 0.1 0.5 0.28 (0.25, 0.31) 0.47 (0.43, 0.53)
Peripheral vascular disease§ 0.8 4.4 0.18 (0.17, 0.19) 0.38 (0.36, 0.39) 
Migraine 8.3 1.1 7.86 (7.73, 7.99) 4.57 (4.49, 4.66) 
Smoking 1§
     Never
     Past 
     Current
51.8
32.8
15.4
33.1
36.7
30.2
-
0.57 (0.56, 0.58)
0.32 (0.32, 0.33)
-
0.40 (0.40, 0.40) 
0.49 (0.49, 0.50) 
BMI2
     Underweight
     Normal
     Overweight §
     Obese
1.5
29.4
32.4
36.6
1.1
21.3
39.3
38.4
1.03 (0.99, 1.06)
1.00
0.60 (0.59, 0.60)
0.70 (0.68, 0.70)
1.21 (1.17, 1.26)
1.0
0.61 (0.61, 0.62) 
0.62 (0.61, 0.63
1 This table includes 3,790,474 persons as 337,514 persons were missing smoking status.
2 This table includes 3,959,919 persons as 168,069 persons were missing height or weight in the period of entry into the
 cohort. 
* p<0.001
§ indicates a clinically meaningful difference (i.e., absolute difference of 2%)
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Table 4: Comorbid mental health conditions in MSD (unadjusted & adjusted ORs, women 
compared to men)*
Unadjusted analysis Adjusted analysis
Women
Percent
Men
Percent
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
Alcohol use disorder§ 3.9 7.7 0.48 (0.47, 0.49) 0.31 (0.30, 0.31) 
Bipolar disorder§ 5.2 2.4 2.29 (2.25, 2.33) 1.47 (1.44, 1.50) 
Drug use disorder 2.5 3.7 0.68 (0.67, 0.70) 0.32 (0.32, 0.33)
Depressive disorder§ 27.1 15.5 2.02 (2.00, 2.04) 1.62 (1.61, 1.63) 
PTSD 10.0 8.2 1.23 (1.22, 1.25) 0.94 (0.92, 0.95)
Anxiety§ 10.7 6.1 1.86 (1.83, 1.88) 1.45 (1.43, 1.47) 
*p<0.001      
§indicates a clinically meaningful difference (i.e., absolute difference of 2%)
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